Global Cell And Gene Therapy Bioanalytical Testing Services Market Size & Outlook

The global cell and gene therapy bioanalytical testing services market size was estimated at USD 541.5 million in 2024 and is projected to reach USD 828.7 million by 2030, growing at a CAGR of 7.4% from 2025 to 2030.
Revenue, 2024 (US$M)
$541.5
Forecast, 2030 (US$M)
$828.7
CAGR, 2025 - 2030
7.4%
Report Coverage
Worldwide

Global cell and gene therapy bioanalytical testing services market, 2018-2030 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Related Markets

Global cell and gene therapy bioanalytical testing services market highlights

  • The global cell and gene therapy bioanalytical testing services market generated a revenue of USD 541.5 million in 2024 and is expected to reach USD 828.7 million by 2030.
  • The market is expected to grow at a CAGR (2025 - 2030) of 7.4% by 2030.
  • In terms of segment, bioavailability & bioequivalence studies accounted for a revenue of USD 206.0 million in 2024.
  • Bioavailability & Bioequivalence Studies is the most lucrative test type segment registering the fastest growth during the forecast period.
  • In terms of region, North America was the largest revenue generating market in 2024.
  • Country-wise, China is expected to register the highest CAGR from 2025 to 2030.

Global data book summary

Market revenue in 2024USD 541.5 million
Market revenue in 2030USD 828.7 million
Growth rate7.4% (CAGR from 2025 to 2030)
Largest segmentBioavailability & bioequivalence studies
Fastest growing segmentBioavailability & Bioequivalence Studies
Historical data covered2018 - 2023
Base year for estimation2024
Forecast period covered2025 - 2030
Quantitative unitsRevenue in USD million
Market segmentationBioavailability & Bioequivalence Studies, Pharmacokinetics, Pharmacodynamics, Other Test Type

Other key industry trends

  • In terms of revenue, the North America accounted for 41.6% of the global cell and gene therapy bioanalytical testing services market in 2024.
  • By country, the U.S. is projected to lead the global market in terms of revenue in 2030.
  • By country, China is the fastest growing regional market and is projected to reach USD 59.4 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Cell and Gene Therapy Bioanalytical Testing Services Market Companies

Name Profile # Employees HQ Website
Prolytix View profile 101-250 Essex Junction, Vermont, United States, North America https://www.goprolytix.com/
KCAS View profile 101-250 Shawnee, Kansas, United States, North America http://www.kcasbio.com
BioAgilytix Labs View profile 501-1000 Durham, North Carolina, United States, North America http://www.bioagilytix.com
Pharmaron Beijing Co Ltd Ordinary Shares - Class H View profile 20295 No. 248 Queen’s Road East, 40th Floor, Dah Sing Financial Centre, Wanchai, Hong Kong, Hong Kong https://www.pharmaron.com
Syneos Health View profile 1001-5000 Morrisville, North Carolina, United States, North America https://www.syneoshealth.com/
Intertek Group PLC View profile 44000 33 Cavendish Square, London, United Kingdom, W1G 0PS https://www.intertek.com
SGS AG View profile 103193 1 Place des Alpes, P.O. Box 2152, Geneva, Switzerland, CH-1211 https://www.sgs.com
IQVIA Holdings Inc View profile 87000 2400 Ellis Road, Durham, NC, United States, 27703 https://www.iqvia.com
Labcorp Holdings Inc View profile 67000 358 South Main Street, Burlington, NC, United States, 27215 https://www.labcorp.com
Charles River Laboratories International Inc View profile 21400 251 Ballardvale Street, Wilmington, MA, United States, 01887 https://www.criver.com
Thermo Fisher Scientific Inc View profile 122000 168 Third Avenue, Waltham, MA, United States, 02451 https://www.thermofisher.com

Global cell and gene therapy bioanalytical testing services market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to cell and gene therapy bioanalytical testing services market will help companies and investors design strategic landscapes.


Bioavailability & bioequivalence studies was the largest segment with a revenue share of 38.04% in 2024. Horizon Databook has segmented the Global cell and gene therapy bioanalytical testing services market based on bioavailability & bioequivalence studies, pharmacokinetics, pharmacodynamics, other test type covering the revenue growth of each sub-segment from 2018 to 2030.


  • Global Cell and Gene Therapy Bioanalytical Testing Services Test Type Outlook (Revenue, USD Million, 2018-2030)
    • Bioavailability & Bioequivalence Studies
    • Pharmacokinetics
    • Pharmacodynamics
    • Other Test Type
  • Global Cell and Gene Therapy Bioanalytical Testing Services Product Type Outlook (Revenue, USD Million, 2018-2030)
    • Cell Therapy
    • Gene Therapy
      • Ex-vivo
      • In-vivo
    • Gene-Modified Cell Therapy
      • CAR T-cell therapies
      • CAR-NK cell therapy
      • TCR-T cell therapy
      • Other
  • Global Cell and Gene Therapy Bioanalytical Testing Services Stage of Development by Product Type Outlook (Revenue, USD Million, 2018-2030)
    • Non-Clinical
      • Gene Therapy
      • Gene-Modified Cell Therapy
      • Cell Therapy
    • Clinical
      • Gene Therapy
      • Gene-Modified Cell Therapy
      • Cell Therapy
  • Global Cell and Gene Therapy Bioanalytical Testing Services Indication Outlook (Revenue, USD Million, 2018-2030)
    • Oncology
    • Infectious Diseases
    • Neurological disorders
    • Rare Diseases
    • Others

Reasons to subscribe to Global cell and gene therapy bioanalytical testing services market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Global cell and gene therapy bioanalytical testing services market databook

  • Our clientele includes a mix of cell and gene therapy bioanalytical testing services market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of global-level data and insights on the Global cell and gene therapy bioanalytical testing services market , including forecasts for subscribers. This global databook contains high-level insights into Global cell and gene therapy bioanalytical testing services market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Global cell and gene therapy bioanalytical testing services market size, by regions, 2018-2030 (US$M)

Top 10 countries: Cell and gene therapy bioanalytical testing services market size, 2024 (US$M)

Global cell and gene therapy bioanalytical testing services market share, by test type, 2024 & 2030 (%, US$M)

Cell and gene therapy bioanalytical testing services market: Opportunity assessment by country

Global cell and gene therapy bioanalytical testing services market, by region, 2024 (US$M)

Global cell and gene therapy bioanalytical testing services market size, by regions, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online